11:04 AM EST, 11/04/2024 (MT Newswires) -- NeurAxis (NRXS) said Monday it received a new 510(k) clearance from the US Food and Drug Administration for its IB-Stim nerve stimulator for functional abdominal pain relief, expanding its indication for use in people between 8 and 21 years of age from a previous indication for 11- to 18-year olds.

IB-Stim is a non-surgical device that sends "gentle" electrical impulses into cranial nerve bundles in the ear, the medical technology company said.

Price: 2.26, Change: -0.33, Percent Change: -12.74